Targeting AP1S1 modulates the unfolded protein response and cell cycle and sensitizes triple-negative breast cancer to erlotinib. // Tissue and Cell. – URL: https://www.sciencedirect.com/science/article/pii/S0040816626008244?dgcid=rss_sd_all
Targeting AP1S1 modulates the unfolded protein response and cell cycle and sensitizes triple-negative breast cancer to erlotinib. Tissue and Cell. https://www.sciencedirect.com/science/article/pii/S0040816626008244?dgcid=rss_sd_all
“Targeting AP1S1 modulates the unfolded protein response and cell cycle and sensitizes triple-negative breast cancer to erlotinib.” Tissue and Cell.
@article{article69513,
title = {Targeting AP1S1 modulates the unfolded protein response and cell cycle and sensitizes triple-negative breast cancer to erlotinib},
journal = {Tissue and Cell},
url = {https://www.sciencedirect.com/science/article/pii/S0040816626008244?dgcid=rss_sd_all}
}